Investor Resources
Conference Call to Review CRN04894 Single-Ascending Dose Results
Aug 10, 2021 at 4:30 PM EDT
Conference call and live audio webcast to discuss the results of the CRN04894 single ascending dose cohorts from the first-in-human Phase 1 clinical study.